Abstract
Objective: The purpose of this study was to observe if luteolin could affect the behavior of cardiac fibroblasts (CFs) on myocardial fibrosis stimulated by angiotensin II (Ang II) and investigate the mechanism involved. Methods: MTT was used to observe the CFs viability and proliferation which was also detected by an EdU staining kit. Cell migration was determined by the transwell chamber. Western blotting was used to examine the protein expression levels of a smooth muscle actin (α -SMA), collagen I and collagen III. The activity of nitric oxide (NO), synthase (NOS), nitrite and cyclic GMP (cGMP) content were measured according to the kits and an enzyme linked immunosorbent assay (ELISA) respectively. Results: The proliferation, migration and expression of α-SMA, collagen I and collagen III in CFs stimulated by Ang II were inhibited by luteolin treatment, and these effects were partly blocked by a combination of treatment with Ang II and NG-nitro-Larginine methyl ester (L-NAME), a non-selective NOS inhibitor, also with 1H-[1,2,4]-oxadiazole -[4,3-a]-quinoxalin-1- one (ODQ), a specific inhibitor of guanylyl cyclase. These effects did not include CFs migration, which showed no apparent difference between Ang II single and together with inhibitors. Luteolin increased the synthesis of total NOS and the content of nitrite and cGMP. Conclusion: These results demonstrate that luteolin is capable of inhibiting the behavior of CFs stimulated by Ang II via up-regulation of NO-cGMP signal pathway.
Keywords: Angiotensin II, cardiac fibroblast, cGMP, fibrosis, luteolin, nitric oxide.
Current Pharmaceutical Biotechnology
Title:Luteolin Antagonizes Angiotensin II-Dependent Proliferation and Collagen Synthesis of Cultured rat Cardiac Fibroblasts
Volume: 16 Issue: 5
Author(s): Tingting Wang, Defeng Pan, Yingying Zhang, Dongye Li, Yanbin Zhang, Tongda Xu, Yuanyuan Luo and Yanfeng Ma
Affiliation:
Keywords: Angiotensin II, cardiac fibroblast, cGMP, fibrosis, luteolin, nitric oxide.
Abstract: Objective: The purpose of this study was to observe if luteolin could affect the behavior of cardiac fibroblasts (CFs) on myocardial fibrosis stimulated by angiotensin II (Ang II) and investigate the mechanism involved. Methods: MTT was used to observe the CFs viability and proliferation which was also detected by an EdU staining kit. Cell migration was determined by the transwell chamber. Western blotting was used to examine the protein expression levels of a smooth muscle actin (α -SMA), collagen I and collagen III. The activity of nitric oxide (NO), synthase (NOS), nitrite and cyclic GMP (cGMP) content were measured according to the kits and an enzyme linked immunosorbent assay (ELISA) respectively. Results: The proliferation, migration and expression of α-SMA, collagen I and collagen III in CFs stimulated by Ang II were inhibited by luteolin treatment, and these effects were partly blocked by a combination of treatment with Ang II and NG-nitro-Larginine methyl ester (L-NAME), a non-selective NOS inhibitor, also with 1H-[1,2,4]-oxadiazole -[4,3-a]-quinoxalin-1- one (ODQ), a specific inhibitor of guanylyl cyclase. These effects did not include CFs migration, which showed no apparent difference between Ang II single and together with inhibitors. Luteolin increased the synthesis of total NOS and the content of nitrite and cGMP. Conclusion: These results demonstrate that luteolin is capable of inhibiting the behavior of CFs stimulated by Ang II via up-regulation of NO-cGMP signal pathway.
Export Options
About this article
Cite this article as:
Wang Tingting, Pan Defeng, Zhang Yingying, Li Dongye, Zhang Yanbin, Xu Tongda, Luo Yuanyuan and Ma Yanfeng, Luteolin Antagonizes Angiotensin II-Dependent Proliferation and Collagen Synthesis of Cultured rat Cardiac Fibroblasts, Current Pharmaceutical Biotechnology 2015; 16 (5) . https://dx.doi.org/10.2174/1389201015666141110142402
DOI https://dx.doi.org/10.2174/1389201015666141110142402 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Disease-Specific iPS Cell Models in Neuroscience
Current Molecular Medicine Pharmacological Targeting in Inherited Arrhythmia Syndromes
Current Medicinal Chemistry Current Indications for Implantable Cardioverter Defibrillators in Non-Ischemic Cardiomyopathies and Channelopathies
Reviews on Recent Clinical Trials The Malignant Obesity Hypoventilation Syndrome (MOHS)
Current Respiratory Medicine Reviews MDMA Toxicity and Pathological Consequences: A Review About Experimental Data and Autopsy Findings
Current Pharmaceutical Biotechnology Iodinated Contrast Media in Diagnostic Imaging: Cardiovascular Side Effects
Current Pharmacogenomics and Personalized Medicine Potential Role of microRNAs in Cardiovascular Disease: Are They up to Their Hype?
Current Cardiology Reviews Cardiac (myo)fibroblast: Novel Strategies for its Targeting Following Myocardial Infarction
Current Pharmaceutical Design Antioxidant Therapy Against Trypanosome Infections: A Review Update
Current Topics in Medicinal Chemistry Pleiotropic Effects of Statin in Therapy in Heart Failure: A Review
Current Vascular Pharmacology A Review of Therapeutic Effects of Curcumin
Current Pharmaceutical Design The Potential Role of Claudins in Regulation of Metastasis and Development of Drug Resistance in Breast Cancer
Clinical Cancer Drugs New and Under Explored Epigenetic Modulators in Search of New Paradigms
Medicinal Chemistry High-output Cardiac Failure: A Forgotten Phenotype in Clinical Practice
Current Cardiology Reviews Fluoxetine and all other SSRIs are 5-HT<sub>2B</sub> Agonists - Importance for their Therapeutic Effects
Current Neuropharmacology Roles of Perilipins in Diseases and Cancers
Current Genomics Successfully Resuscitated Sudden Cardiac Death in a Young Homosexual Male with HIV Myocarditis
Current HIV Research PREFACE: Cardiovascular and Hematological Medicine in 2015 - Advances and Insights
Cardiovascular & Hematological Agents in Medicinal Chemistry Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Current Pharmaceutical Design Trypanosomatid Parasites Causing Neglected Diseases
Current Medicinal Chemistry